JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
PUT
MetLife
MET
$62.4B
| $12.6M | ﹤0.01% |
222,200
-417,900
| -65% | -$23.2M |
|
2027
CALL
Cleveland-Cliffs
CLF
$6.49B
| $12.6M | ﹤0.01% |
749,000
+733,400
| +4,701% | +$11.6M |
|
2028
Sterling Infrastructure
STRL
$15.2B
| $12.5M | ﹤0.01% |
224,416
+48,923
| +28% | +$2.17M |
|
2029
Federated Hermes
FHI
$4.56B
| $12.5M | ﹤0.01% |
349,173
-82,688
| -19% | -$3.2M |
|
2030
Diodes
DIOD
$3.5B
| $12.5M | ﹤0.01% |
135,162
+2,434
| +2% | +$215K |
|
2031
PUT
AstraZeneca
AZN
$269B
| $12.5M | ﹤0.01% |
+87,050
| New | +$12.8M |
|
2032
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$1.93B
| $12.5M | ﹤0.01% |
445,573
+14,175
| +3% | +$393K |
|
2033
Axsome Therapeutics
AXSM
$11.7B
| $12.4M | ﹤0.01% |
173,232
-924
| -0.5% | -$68.2K |
|
2034
Materion
MTRN
$3.94B
| $12.4M | ﹤0.01% |
108,993
-4,101
| -4% | -$445K |
|
2035
TTM Technologies
TTMI
$10.6B
| $12.4M | ﹤0.01% |
895,363
-394,511
| -31% | -$5.09M |
|
2036
Atara Biotherapeutics
ATRA
$72.6M
| $12.4M | ﹤0.01% |
308,810
+2,579
| +0.8% | +$146K |
|
2037
Enpro
NPO
$6.26B
| $12.4M | ﹤0.01% |
93,052
+9,998
| +12% | +$1.06M |
|
|
VRNT
2038
DELISTED
Verint Systems
VRNT
| $12.4M | ﹤0.01% |
353,404
-121,214
| -26% | -$4.37M |
|
2039
Encore Capital Group
ECPG
$2.01B
| $12.4M | ﹤0.01% |
254,609
-8,650
| -3% | -$421K |
|
2040
National Health Investors
NHI
$3.79B
| $12.4M | ﹤0.01% |
235,898
+29,060
| +14% | +$1.5M |
|
2041
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $12.3M | ﹤0.01% |
307,016
+180,788
| +143% | +$7.4M |
|
2042
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.45B
| $12.3M | ﹤0.01% |
397,129
-68,881
| -15% | -$2.09M |
|
2043
PUT
IBM
IBM
$213B
| $12.3M | ﹤0.01% |
92,000
-107,500
| -54% | -$13.9M |
|
2044
Euronet Worldwide
EEFT
$3.19B
| $12.3M | ﹤0.01% |
104,846
-497
| -0.5% | -$55.6K |
|
2045
CALL
General Motors
GM
$80.9B
| $12.3M | ﹤0.01% |
319,100
+160,200
| +101% | +$5.54M |
|
2046
Reynolds Consumer Products
REYN
$5.42B
| $12.3M | ﹤0.01% |
435,286
-50,120
| -10% | -$1.39M |
|
|
IRBT
2047
DELISTED
iRobot
IRBT
| $12.3M | ﹤0.01% |
270,732
-365,506
| -57% | -$14.6M |
|
2048
Ascendis Pharma A/S
ASND
$16.5B
| $12.2M | ﹤0.01% |
137,145
+61,148
| +80% | +$5.32M |
|
2049
Cytokinetics
CYTK
$10.6B
| $12.2M | ﹤0.01% |
375,005
+18,935
| +5% | +$701K |
|
2050
Kadant
KAI
$3.58B
| $12.2M | ﹤0.01% |
55,075
-1,328
| -2% | -$266K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.